Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for ''
published presentations and documents on DocSlides.
Rare is not rare’
by breezeibm
1 / 3 ‘ New scientific paper confi rms 300 m il...
Page 2 of 6etal Orphanet Journal of Rare Diseases 2022 17
by walsh
begs the question: how long will it take other cou...
Management of Rare Diseases: An Integrated Approach to Break Down Barriers and Facilitate Patient A
by tatiana-dople
“2. nd. World Congress on Rare Diseases and Or...
Tackling Rare Diseases
by conchita-marotz
in the United States. Paul Melmeyer. Associate. ...
Hilgers RD Knig F Molenberghs G Senn S J Rare Dis Res Treat 2
by emma
Page 53 of 60 Ralf‐Dieter Hilgers*, Franz König...
6. Priority diseases and reasons for
by kaptainpositive
inclusion 1 6.19 Rare diseases See Background Pape...
GENE THERAPIES IN RARE DISEASEFROM R&D TO REGULATORY APPROVAL ...
by disclaimercanon
ARTICLEAdvancements in science and technology have...
Rare Action network
by karlyn-bohler
®. Presentation by NORD. June 16, 2014. NORD. Le...
Improving the process of rare disease treatment development
by lindy-dunigan
“. EMERGING THERAPIES FOR RARE DISEASES. ”. ...
Accessing the Accelerated Approval Pathway with a Rare Neur
by karlyn-bohler
Batten Disease. June 29-30, 2010 . FDA Public Mee...
research partners. The DMCC enables uniform high-quality data collecti
by eatsui
About NCATS and Translational ScienceNCATS is one ...
2 Mission Statement
by jane-oiler
Orphan diseases represent a collection of disorde...
Panel 1 - The
by phoebe-click
right to . health. of people living . with. rar...
A Way to Benefit from Cooperation:
by myesha-ticknor
Latvian . Alliance for Rare . Diseases. Baiba . Z...
RarePurposing Past Successes and Future Economics
by phoebe-click
Dr. Bruce E. Bloom. President and Chief Science O...
Clinical Investigator Training Course
by luanne-stotts
Issues in Clinical Trial Design for Rare Diseases...
CHI-California Healthcare Institute is a non-profit public policy rese
by bigboybikers
biomedical R&D industry. CHI represents more than ...
rarediseasedayus
by stella
Rare Disease DayFrequently Asked QuestionsWhat is ...
Procedural document
by molly
| Version 02 | March 2020 : Orphanet nomenclatu...
RARE DISEASES AND THE EUROPEAN HEALTH DATA SPACE
by wesley
Juan Fernando Muñoz . General . Secretary. . for...
The Budget Impact of Drugs Treating Rare Diseases in Canada
by myesha-ticknor
: A 2007-2013 MIDAS Sales Data Analysis. April 14...
Genetic Approaches to Rare Diseases:
by alida-meadow
What has worked and what may work for AHC. Erin L...
Missing Heritability
by test
Lipika. Ray. 4th . June 2010. Heritability:. P...
Going Beyond the Current Regulatory and Incentives Framewor
by calandra-battersby
A new proposal to foster greater orphan drug deve...
CASE SERIES OF RARE BREAST DISEASES AND THEIR UNUSUAL PRESE
by tawny-fly
Presenting Author: Dr. . Sariya. . Mohammadi. . ...
The Budget Impact of Drugs Treating Rare Diseases in Canada
by phoebe-click
: A 2007-2013 MIDAS Sales Data Analysis. April 14...
CASE SERIES OF RARE BREAST DISEASES AND THEIR UNUSUAL PRESENTATION
by maxasp
Presenting Author: Dr. . Sariya. . Mohammadi. . J...
NEWS FROM NORD
by hoodrona
careg...
Integrated social and
by reese
SECTORhealthcare servicesCOUNTRYRomaniaLEAD ORGANI...
Stockholm Sweden
by genevieve
PRESS RELEASE 28 February 2020 Swedish Orphan Bio...
Social Economic Burden and Health-related Quality of Life in Patients with
by eliza
Rare Diseases in Europe. (BURQOL-RD). A/101205. ww...
Session V: Perspectives from Patient Organizations
by taylor
Jane Perlmutter. The Gemini Group. CTTI. John Adam...
Perspective on access
by osullivan
. to. . care. and . on. European . cooperation....
Current Biology Vol 22 No 17
by lucy
As an alternative, Speakman has putforward a non-a...
Genetics Clinic Evaluation and Support Resources
by cecilia
Farah Ladha, MS, CGC. Certified Genetic Counselor ...
Ethical and practical challenges of organising
by lily
c. linical trials in small . p. opulations . There...
Information Fusion on Human Disease Network in Taiwan
by smith
Kuang. -Chi Chen, Ph.D.. Dept. of Medical Informat...
ILAE / IBE collaboration
by friendma
European. perspective. EUCARE session, Porto, Aug...
March 20th,
by lois-ondreau
2014. Potential elimination of the Orphan Drug ...
Translational Research through Public-Private Partnerships
by faustina-dinatale
65. th. Annual . Bohan. Lecture. Scott J. Weir...
Load More...